← All organizations
Highest phase reached
Phase 4
First clinical trial
May 1, 2008Last known activity
Jun 25, 2025
Timeline
1990s
- Jan 1, 1999
Korea Health Industry Development Institute— Founded
Drugs by trial phase (16 distinct, 15 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
- Alzheimer Disease
- Anxiety Disorders
- Aphasia, Primary Progressive
- Attention Deficit Disorder with Hyperactivity
- Cognitive Dysfunction
- Communicable Diseases
- Disease
- Dyspepsia
- Frontotemporal Dementia
- Hyperkinesis
- Infections
- Neurodegenerative Diseases
- Obesity
- Osteoporosis
- Parkinson Disease
- Pick Disease of the Brain
- Respiratory Tract Infections
- Tendon Injuries
- Tennis Elbow
Recent trials (20)
- NCT06977594CollaboratorN/AJun 25, 2025
- NCT05957822CollaboratorPhase 4Nov 1, 2023
- NCT05806346CollaboratorN/AAug 1, 2023
- NCT03510572CollaboratorEarly Phase 1Jun 4, 2018
- NCT03449082CollaboratorPhase 2Mar 10, 2018
- NCT02656498CollaboratorPhase 2Jan 1, 2016
- NCT01724099CollaboratorPhase 2/Phase 3Oct 1, 2012
- NCT02592161Reponsible party - principal investigatorPhase 2Apr 1, 2012
- NCT02592161Lead sponsorPhase 2Apr 1, 2012
- NCT01362114Reponsible party - principal investigatorPhase 4Jul 1, 2010
- NCT01362114Lead sponsorPhase 4Jul 1, 2010
- NCT05482828Reponsible party - principal investigatorPhase 2May 31, 2010
- NCT05482828Lead sponsorPhase 2May 31, 2010
- NCT00987805Reponsible party - principal investigatorPhase 4Sep 1, 2009
- NCT00987805Lead sponsorPhase 4Sep 1, 2009
Details
- Founded
- Cheongju, KR Jan 1, 1999
- Last known activity
- Jun 25, 2025